The protein was initially described in 1965 by Moore et al.[29] and subsequently, the alteration of S100B gene has been associated with many neurological diseases including Alzheimer’s, amyotrophic lateral sclerosis and epilepsy[30–32]. This evidence concerns the gene S100B and nervous system disorder.